Cyrus Biotechnology logo

Cyrus Biotechnology

cyrusbio.com

Cyrus Biotechnology develops computationally engineered biologics from natural proteins for therapeutic applications, with lead programs targeting severe autoimmune diseases and acute respiratory distress syndrome. The company uses protein design algorithms and laboratory methods to create novel variants and fusion proteins, aiming to provide superior efficacy and address unmet medical needs.

Facts

HQ
Seattle, Washington, US
Sectors
Biotechnology Research
Founded
2014
Type
Corporation Seattle business license
Employees
17
Registered name
Cyrus Biotechnology Inc Seattle business license
Stage
Series B
Members see funding amounts.
.
Founders
David Baker

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about Cyrus Biotechnology

See all 15

Seattle’s UW research, Amazon alumni and military adjacency fuel startups building high-stakes, regulation-ready AI for biotech, finance and government

A Seattle high-school intern argues that strict school AI rules illuminated why AI must be disciplined in high-stakes domains, and describes how Seattle's research institutions (notably UW and the David Baker ecosystem), Amazon alumni, and military adjacency produce founders building accountable, regulation-ready AI for biotech, finance, and government.

Nobel Laureate David Baker Drives Protein Design Innovation and Startup Growth at University of Washington

David Baker, Nobel Prize winner and head of the Institute for Protein Design at the University of Washington, is focused on advancing protein design research and entrepreneurship, having helped spawn over 20 startups in Seattle's biotech hub. He plans to continue accelerating scientific innovation in the field, which develops new proteins for therapeutics, vaccines, and materials.

People

  • Lucas Nivon
    Lucas Nivon Executive Officer, Director, Co-Founder and Chief Executive Officer
  • Yifan Song Director, Co-founder and Chief Technology Officer
  • Erik Procko Executive, Chief Scientific Officer

Online

Questions about Cyrus Biotechnology

What is Cyrus Biotechnology?

Cyrus Biotechnology is a startup based in Seattle, Washington, US that develops computationally engineered biologics from natural proteins for therapeutic applications. Its lead programs target severe autoimmune diseases and acute respiratory distress syndrome.

What is Cyrus Biotechnology known for?

Cyrus Biotechnology uses protein design algorithms and laboratory methods to create novel protein variants and fusion proteins for therapeutic applications.

What has Cyrus Biotechnology been in the news for?

Ascend.vc reported in January 2026 on Seattle startups building regulation-ready AI for biotech, finance and government. GeekWire reported in December 2024 on David Baker’s protein design innovation and startup growth at University of Washington.

Who are the people behind Cyrus Biotechnology?

Lucas Nivon is co-founder, chief executive officer and executive officer at Cyrus Biotechnology. Yifan Song is co-founder and chief technology officer, and Erik Procko is chief scientific officer.

Who invested in Cyrus Biotechnology, and how much has it raised?

Members of Seattle Flow see Cyrus Biotechnology's funding rounds, amounts and investors on its Funding tab. Joining is free.

Where is Cyrus Biotechnology based?

Cyrus Biotechnology is based in Seattle, Washington, US.